Duygu Yazar Toyran

Director, Pharmacovigilance Quality (pv Qa) at ADC Therapeutics

Duygu Yazar Toyran is an experienced professional in pharmacovigilance and regulatory affairs, currently serving as the Director of Pharmacovigilance Quality at ADC Therapeutics since August 2021. Prior roles include Associate Director of Pharmacovigilance Systems and Operations at ADC Therapeutics and various positions at Novartis from January 2015 to July 2021, including Country Patient Safety Head and Senior Patient Safety Specialist. Duygu also worked as an International Markets Technical Regulatory Affairs Specialist at DEVA Holding A.Ş. from August 2013 to December 2014. Academic qualifications include a Master of Science in Pharmacology from King's College London and a Bachelor of Science in Pharmacy from Istanbul University, along with additional education in Business Administration from the London School of Economics.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ADC Therapeutics

2 followers

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.


Industries

Employees

201-500

Links